Abbott Laboratories: Cardiovascular Disease Has Been A Tailwind, But Things Could Change Seeking Alpha, 11 Sep 2024 Follow Summary Cardiovascular disease is rising, presenting an opportunity for investors; Abbott Laboratories is well-positioned…